PALATIN TECHNOLOGIES INC (PTN)
Data as of , from SEC Form 4 filings.
See up to 3 months of PTN. The 7-day demo opens the 1M and 3M ranges and puts PTN on your watchlist.
Start 7-day demoLatest PTN insider trades
About PALATIN TECHNOLOGIES INC (PTN)
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor (MCR) system. Its product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical need and commercial potential. It is also developing, dependent on resources for development activities, MC1R agonist products, with potential to treat inflammatory and autoimmune diseases, such as dry eye disease, which is also known as keratoconjunctivitis sicca, uveitis, diabetic retinopathy, and inflammatory bowel disease. It has one operating segment life science.
- CRANBURY, NJ
- 25
- 1993
- XNAS
PTN Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Tax withholding / forfeiture | 6 | 489 | |
| Other acquisition / disposition | 3 | 7,500 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
PTN insider transactions (Form 4)
5319 Form 4 filings on record, the earliest from May 13, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Arlene Morris - Director | Other | Stock Option (Right to Buy) | 2,400 | $0.00 | - | |
| Alan W. Dunton - Director | Other | StockOption (Right toBuy) | 2,200 | $0.00 | - | |
| John K. A. Prendergast - Director | Other | Stock Option (Right to Buy) | 2,900 | $0.00 | - | |
| Carl Spana - Officer | Tax withholding / forfeiture | Common Stock | 33 footnote F1 | $11.77 footnote F1 | $388 | |
| Carl Spana - Officer | Tax withholding / forfeiture | Common Stock | 119 footnote F2 | $11.72 footnote F2 | $1K | |
| Carl Spana - Officer | Tax withholding / forfeiture | Common Stock | 142 footnote F3 | $14.34 footnote F3 | $2K | |
| ||||||
| Stephen T. Wills - Officer | Tax withholding / forfeiture | Common Stock | 22 footnote F1 | $11.77 footnote F1 | $259 | |
| Stephen T. Wills - Officer | Tax withholding / forfeiture | Common Stock | 79 footnote F2 | $11.72 footnote F2 | $926 | |
| Stephen T. Wills - Officer | Tax withholding / forfeiture | Common Stock | 94 footnote F3 | $14.34 footnote F3 | $1K | |
| ||||||
| Stephen T. Wills - Officer | Tax withholding / forfeiture | Common Stock | 26 | $21.38 | $556 | |
| Stephen T. Wills - Officer | Tax withholding / forfeiture | Common Stock | 91 | $21.38 | $2K | |
| Stephen T. Wills - Officer | Tax withholding / forfeiture | Common Stock | 95 | $21.38 | $2K | |
| Carl Spana - Officer | Tax withholding / forfeiture | Common Stock | 40 | $21.38 | $855 | |
| Carl Spana - Officer | Tax withholding / forfeiture | Common Stock | 138 | $21.38 | $3K | |
| Carl Spana - Officer | Tax withholding / forfeiture | Common Stock | 143 | $21.38 | $3K | |
| Stephen T. Wills - Officer | Open-market sale | Common Stock | 565 footnote F1 | $16.74 footnote F1 | $9K | |
| ||||||
| Stephen T. Wills - Officer | Grant or award | Common Stock | 95 footnote F1 | $0.00 footnote F1 | - | |
| Stephen T. Wills - Officer | Grant or award | Common Stock | 330 footnote F2 | $0.00 footnote F2 | - | |
| Stephen T. Wills - Officer | Grant or award | Common Stock | 345 footnote F3 | $0.00 footnote F3 | - | |
| Stephen T. Wills - Officer | Grant or award | Stock Option (Right to Buy) | 142 | $0.00 | - | |
| Stephen T. Wills - Officer | Grant or award | Stock Option (Right to Buy) | 518 | $0.00 | - | |
| Stephen T. Wills - Officer | Grant or award | Stock Option (Right to Buy) | 495 | $0.00 | - | |
| ||||||
| Arlene Morris - Director | Grant or award | Stock Option (Right to Buy) | 2,400 | $0.00 | - | |
| Arlene Morris - Director | Grant or award | Stock Option (Right to Buy) | 2,400 | $0.00 | - | |
| Carl Spana - Officer | Grant or award | Common Stock | 110 footnote F1 | $0.00 footnote F1 | - | |
| Carl Spana - Officer | Grant or award | Common Stock | 380 footnote F2 | $0.00 footnote F2 | - | |
| Carl Spana - Officer | Grant or award | Common Stock | 395 footnote F3 | $0.00 footnote F3 | - | |
| Carl Spana - Officer | Grant or award | Stock Option (Right to Buy) | 595 | $0.00 | - | |
| Carl Spana - Officer | Grant or award | Stock Option (Right to Buy) | 568 | $0.00 | - | |
| Carl Spana - Officer | Grant or award | Stock Option (Right to Buy) | 163 | $0.00 | - | |
| ||||||
| John K. A. Prendergast - Director | Grant or award | Common Stock | 1,300 footnote F1 | $0.00 footnote F1 | - | |
| John K. A. Prendergast - Director | Grant or award | Common Stock | 1,300 footnote F2 | $0.00 footnote F2 | - | |
| John K. A. Prendergast - Director | Grant or award | Stock Option (Right to Buy) | 1,600 | $0.00 | - | |
| John K. A. Prendergast - Director | Grant or award | Stock Option (Right to Buy) | 1,600 | $0.00 | - | |
| ||||||
| Alan W. Dunton - Director | Grant or award | Common Stock | 1,000 footnote F1 | $0.00 footnote F1 | - | |
| Alan W. Dunton - Director | Grant or award | Common Stock | 1,000 footnote F2 | $0.00 footnote F2 | - | |
| Alan W. Dunton - Director | Grant or award | Stock Option (Right to Buy) | 1,200 | $0.00 | - | |
| Alan W. Dunton - Director | Grant or award | Stock Option (Right to Buy) | 1,200 | $0.00 | - | |
| ||||||
| Stephen T. Wills - Officer | Tax withholding / forfeiture | Common Stock | 33 footnote F1 | $8.00 footnote F1 | $264 | |
| Stephen T. Wills - Officer | Tax withholding / forfeiture | Common Stock | 22 footnote F2 | $8.00 footnote F2 | $176 | |
| Stephen T. Wills - Officer | Tax withholding / forfeiture | Common Stock | 79 footnote F3 | $8.00 footnote F3 | $632 | |
| Stephen T. Wills - Officer | Tax withholding / forfeiture | Common Stock | 95 footnote F4 | $5.50 footnote F4 | $523 | |
| ||||||
| Carl Spana - Officer | Tax withholding / forfeiture | Common Stock | 51 footnote F1 | $8.00 footnote F1 | $408 | |
| Carl Spana - Officer | Tax withholding / forfeiture | Common Stock | 33 footnote F2 | $8.00 footnote F2 | $264 | |
| Carl Spana - Officer | Tax withholding / forfeiture | Common Stock | 119 footnote F3 | $8.00 footnote F3 | $952 | |
| Carl Spana - Officer | Tax withholding / forfeiture | Common Stock | 142 footnote F4 | $5.50 footnote F4 | $781 | |
| ||||||
| Stephen T. Wills - Officer | Open-market purchase | Series D Preferred Stock | 1,500 | $150,000.00 | $225.00M | |
| Stephen T. Wills - Officer | Open-market purchase | Series I warrants | 2,727,272 | $0.00 | - | |
| Carl Spana - Officer | Open-market purchase | Series D Preferred Stock | 1,500 | $150,000.00 | $225.00M | |
| Carl Spana - Officer | Open-market purchase | Series I warrants | 2,727,272 | $0.00 | - | |
| Alan W. Dunton | Open-market purchase | Series D Preferred Stock | 200 | $20,000.00 | $4.00M | |
| Alan W. Dunton | Open-market purchase | Series I warrants | 363,636 | $0.00 | - | |
| Robert K. Deveer Jr. | Open-market purchase | Common Stock | 100,000 | $0.10 | $10K | |
Item 5.07, 9.01
Item 3.01, 7.01, 9.01
PTN insider trading FAQ
What is the latest insider trade for PTN?
PALATIN TECHNOLOGIES INC (PTN) had 5 insider filings in the last 90 days, with the most recent on 2026-08-05. The full record for PTN runs to 19 Form 4 filings, the earliest from 2025-05-13. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying PTN stock?
No insider purchases of PTN were filed in the last 90 days. 7 purchases are on record for this company.
How many insiders are selling PTN stock?
No insider sales of PTN were filed in the last 90 days. 1 sale is on record for this company.
Where can I see PTN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects PTN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Arlene Morris view on EDGAR
- - Alan W. Dunton view on EDGAR
- - John K. A. Prendergast view on EDGAR
- - Carl Spana view on EDGAR
- - Stephen T. Wills view on EDGAR
- - Stephen T. Wills view on EDGAR
- - Carl Spana view on EDGAR
- - Stephen T. Wills view on EDGAR
- - Stephen T. Wills view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where PTN's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow PTN with a 7-day demo
- PTN on your watchlist
- Every PTN Form 4 filing on record
- Up to 3 months of PTN price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
